Edwards Lifesciences (EW) Other Non-Current Liabilities (2016 - 2025)
Edwards Lifesciences (EW) has 17 years of Other Non-Current Liabilities data on record, last reported at $362.6 million in Q3 2025.
- For Q3 2025, Other Non-Current Liabilities rose 12.4% year-over-year to $362.6 million; the TTM value through Sep 2025 reached $362.6 million, up 12.4%, while the annual FY2024 figure was $384.6 million, 53.04% up from the prior year.
- Other Non-Current Liabilities reached $362.6 million in Q3 2025 per EW's latest filing, down from $421.6 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $421.6 million in Q2 2025 and bottomed at $25.7 million in Q3 2022.
- Average Other Non-Current Liabilities over 5 years is $252.2 million, with a median of $261.8 million recorded in 2024.
- Peak YoY movement for Other Non-Current Liabilities: tumbled 90.2% in 2022, then skyrocketed 859.16% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $267.3 million in 2021, then crashed by 90.2% to $26.2 million in 2022, then surged by 859.16% to $251.3 million in 2023, then soared by 53.04% to $384.6 million in 2024, then fell by 5.72% to $362.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $362.6 million in Q3 2025, $421.6 million in Q2 2025, and $357.6 million in Q1 2025.